Zobrazeno 1 - 10
of 160
pro vyhledávání: '"George Z, Rassidakis"'
Autor:
Ioannis Zerdes, Emmanouil G. Sifakis, Alexios Matikas, Sebastian Chrétien, Nicholas P. Tobin, Johan Hartman, George Z. Rassidakis, Jonas Bergh, Theodoros Foukakis
Publikováno v:
Molecular Oncology, Vol 14, Iss 5, Pp 951-963 (2020)
Gene and protein expression of programmed death‐ligand 1 (PD‐L1) are prognostic in early breast cancer (BC), but their prognostic information is inconsistent at least in some biological subgroups. The validated prognostic gene signatures (GS) in
Externí odkaz:
https://doaj.org/article/35cba073e6ea4fa1bf36cbaeb5a2366b
Autor:
Pingnan Xiao, Monika Dolinska, Lakshmi Sandhow, Makoto Kondo, Anne-Sofie Johansson, Thibault Bouderlique, Ying Zhao, Xidan Li, Marios Dimitriou, George Z. Rassidakis, Eva Hellström-Lindberg, Nagahiro Minato, Julian Walfridsson, David T. Scadden, Mikael Sigvardsson, Hong Qian
Publikováno v:
Blood Advances, Vol 2, Iss 5, Pp 534-548 (2018)
Abstract: Mutations of signal-induced proliferation-associated gene 1 (SIPA1), a RAP1 GTPase-activating protein, were reported in patients with juvenile myelomonocytic leukemia, a childhood myelodysplastic/myeloproliferative neoplasm (MDS/MPN). Sipa1
Externí odkaz:
https://doaj.org/article/9062250244da4e5ca36413d3405d4e8e
Autor:
Ken H. Young, Gordon J. Freeman, Yong Li, George Z. Rassidakis, L. Jeffrey Medeiros, Lan V. Pham, Jason R. Westin, Jane N. Winter, J. Han van Krieken, Miguel A. Piris, Michael B. Møller, Andrés J.M. Ferreri, Maurilio Ponzoni, Eric D. Hsi, Govind Bhagat, Hua You, Wayne Tam, Karen Dybkær, Jing Wang, Alexandar Tzankov, Hongwei Zhang, Xiaohong Tan, Yi Miao, Carlo Visco, Ganiraju C. Manyam, Raul Torres-Ruiz, Sandra Rodríguez-Perales, Nicholas Hoe, Bing Xu, Raghav Padmanabhan, Qingyan Au, Min Xiao, Ziju Y. Xu-Monette
PD-1/L1 and CTLA-4 blockade immunotherapies have been approved for 13 types of cancers and are being studied in diffuse large B-cell lymphoma (DLBCL), the most common aggressive B-cell lymphoma. However, whether both PD-1 and CTLA-4 checkpoints are a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2004bbfc600786a4399e7da7d1869196
https://doi.org/10.1158/2326-6066.c.6548953.v1
https://doi.org/10.1158/2326-6066.c.6548953.v1
Autor:
Ken H. Young, Gordon J. Freeman, Yong Li, George Z. Rassidakis, L. Jeffrey Medeiros, Lan V. Pham, Jason R. Westin, Jane N. Winter, J. Han van Krieken, Miguel A. Piris, Michael B. Møller, Andrés J.M. Ferreri, Maurilio Ponzoni, Eric D. Hsi, Govind Bhagat, Hua You, Wayne Tam, Karen Dybkær, Jing Wang, Alexandar Tzankov, Hongwei Zhang, Xiaohong Tan, Yi Miao, Carlo Visco, Ganiraju C. Manyam, Raul Torres-Ruiz, Sandra Rodríguez-Perales, Nicholas Hoe, Bing Xu, Raghav Padmanabhan, Qingyan Au, Min Xiao, Ziju Y. Xu-Monette
Supplementary Figures S1 to S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::457727be1620a46e488c64d429f6ad02
https://doi.org/10.1158/2326-6066.22538953
https://doi.org/10.1158/2326-6066.22538953
Autor:
François X. Claret, Douglas B. Evans, Linus Ho, Paul Chiao, Qingxiu Zhang, Ling Tian, George Z. Rassidakis, Anita L. Korapati, Maria A. Kouvaraki
Reduced expression of p27 has been associated with poor prognosis in most human cancers, including pancreatic adenocarcinoma. Jun activation domain–binding protein 1 (JAB1), an activator protein (AP-1) coactivator, previously implicated in p27 degr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e70936ae4322cd40cfb891e6cd666c
https://doi.org/10.1158/0008-5472.c.6494451
https://doi.org/10.1158/0008-5472.c.6494451
Autor:
George Z. Rassidakis, Francois-Xavier Claret, Ling Tian, Jeong Hee Cho-Vega, Coralyn Atwell, Vasiliki Leventaki, L. Jeffrey Medeiros, Francisco Vega
Anaplastic lymphoma kinase (ALK)–positive anaplastic large cell lymphoma (ALCL) frequently carries the t(2;5)(p23;q35) resulting in aberrant expression of chimeric nucleophosmin-ALK. Previously, nucleophosmin-ALK has been shown to activate phosphat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d68a8a03fed1f73d314a011690a171d
https://doi.org/10.1158/0008-5472.c.6494354.v1
https://doi.org/10.1158/0008-5472.c.6494354.v1
Autor:
George Z. Rassidakis, Francois-Xavier Claret, Ling Tian, Jeong Hee Cho-Vega, Coralyn Atwell, Vasiliki Leventaki, L. Jeffrey Medeiros, Francisco Vega
Supplementary Figure S1 from Activation of Mammalian Target of Rapamycin Signaling Pathway Contributes to Tumor Cell Survival in Anaplastic Lymphoma Kinase–Positive Anaplastic Large Cell Lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f3bb37a1c6fbfb16c1d1d0fb4e3edbe
https://doi.org/10.1158/0008-5472.22364774.v1
https://doi.org/10.1158/0008-5472.22364774.v1
Autor:
Panaretakis, Dimitrios Chioureas, Janina Beck, George Baltatzis, Ioulia Vardaki, Pedro Fonseca, Nikolaos Tsesmetzis, Francisco Vega, Vasiliki Leventaki, Aristides G. Eliopoulos, Elias Drakos, George Z. Rassidakis, Theocharis
Publikováno v:
Cancers; Volume 14; Issue 12; Pages: 2939
The oncogenic pathways activated by the NPM-ALK chimeric kinase of ALK+ anaplastic large cell lymphoma (ALCL) are well characterized; however, the potential interactions of ALK signaling with the microenvironment are not yet known. Here we report tha
Autor:
Konstantina Stathopoulou, Dimitra Vyrla, L. Jeffrey Medeiros, Elias Drakos, George Z. Rassidakis, Vaios Sinatkas, Vasilios Atsaves, Ioanna Xagoraris, Jingjing Ye, Vasiliki Leventaki
Publikováno v:
Leukemia & Lymphoma. 62:1563-1573
We hypothesized that murine double minute X (MDMX), a negative p53-regulator, may be involved in dysfunctional p53-signaling in anaplastic large cell lymphoma (ALCL), anaplastic lymphoma kinase (ALK)-positive and ALK-negative, characterized frequentl
Autor:
Dimitrios, Chioureas, Janina, Beck, George, Baltatzis, Ioulia, Vardaki, Pedro, Fonseca, Nikolaos, Tsesmetzis, Francisco, Vega, Vasiliki, Leventaki, Aristides G, Eliopoulos, Elias, Drakos, George Z, Rassidakis, Theocharis, Panaretakis
Publikováno v:
Cancers. 14(12)
The oncogenic pathways activated by the NPM-ALK chimeric kinase of ALK+ anaplastic large cell lymphoma (ALCL) are well characterized; however, the potential interactions of ALK signaling with the microenvironment are not yet known. Here we report tha